Form 8-K - Current report:
SEC Accession No. 0001558370-25-009663
Filing Date
2025-07-28
Accepted
2025-07-28 17:04:51
Documents
15
Period of Report
2025-07-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20250728x8k.htm   iXBRL 8-K 45395
2 EX-99.1 tmb-20250728xex99d1.htm EX-99.1 26607
3 GRAPHIC tmb-20250728xex99d1002.jpg GRAPHIC 9319
  Complete submission text file 0001558370-25-009663.txt   208880

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20250728.xsd EX-101.SCH 3988
5 EX-101.DEF tmb-20250728_def.xml EX-101.DEF 2805
6 EX-101.LAB tmb-20250728_lab.xml EX-101.LAB 16546
7 EX-101.PRE tmb-20250728_pre.xml EX-101.PRE 9654
17 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250728x8k_htm.xml XML 4679
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 251156363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)